Literature DB >> 20837931

Post-heart transplant survival is inferior at low-volume centers across all risk strata.

Mark J Russo1, Alexander Iribarne, Rachel Easterwood, Ali N Ibrahimiye, Ryan Davies, Kimberly N Hong, Deborah D Ascheim, Annetine C Gelijns, Yoshifumi Naka.   

Abstract

BACKGROUND: Previous studies have demonstrated a relationship between increasing center volume and cardiac transplant outcomes. The purpose of this study was to confirm a relationship between post-heart transplant outcomes and center experience and to determine whether this relationship persists among low- and high-risk heart transplant recipient-donor pairs. METHODS AND
RESULTS: The United Network for Organ Sharing (UNOS) provided deidentified patient-level data. Analysis included 8029 heart transplant recipients aged ≥18 years and transplanted between January 1, 2001 and December 31, 2006 with follow-up available through February 3, 2009. The primary outcome was observed 1-year posttransplant graft survival. Multivariable logistic regression was used to calculate expected 1-year survival for recipients. Threshold analysis identified 3 discrete risk groups of transplant recipients: high-risk, moderate-risk, and low-risk. Three discrete risk strata for center volume: low (<10.5 recipients/yr), intermediate (10.5 to 47 recipients/yr), and high (>47 recipients/yr) were also identified. χ(2) test was used to compare 1-year survival at low- and intermediate- with high-volume centers. In multivariable logistic regression analysis, annual center volume was significantly associated with posttransplant graft survival at 1 year (odds ratio [OR]=0.995, 0.992 to 0.999; P=0.010) and primary graft failure (OR=0.985, 0.972 to 0.997; P=0.015), but not stroke (OR=0.996, 0.990 to 1.003; P=0.295), infection (OR=1.001, 0.998 to 1.003; P=0.613), or dialysis (OR=1.001, 0.997 to 1.005; P=0.522). Log-rank test demonstrated significant difference in survival between volume groups with respect to high-risk (P=0.0032) and low-risk (P=0.00415), but not moderate-risk (P=0.128) patients.
CONCLUSIONS: A direct relationship existed between increasing center volume and improved graft survival. Across all recipient-donor pair risk strata, posttransplant graft survival at 1 year was significantly lower at low-volume centers. The volume-outcomes relationship was strongest in the highest-risk recipient-donor category.

Entities:  

Mesh:

Year:  2010        PMID: 20837931     DOI: 10.1161/CIRCULATIONAHA.109.926659

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

1.  Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices.

Authors:  George J Arnaoutakis; Timothy J George; Arman Kilic; Claude A Beaty; Eric S Weiss; John V Conte; Ashish S Shah
Journal:  Ann Thorac Surg       Date:  2012-03-17       Impact factor: 4.330

2.  Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database.

Authors:  George J Arnaoutakis; Yue Zhao; Timothy J George; Christopher M Sciortino; Patrick M McCarthy; John V Conte
Journal:  Ann Thorac Surg       Date:  2012-05-23       Impact factor: 4.330

3.  Impact of Insurance Type on Initial Rejection Post Heart Transplant.

Authors:  Khadijah Breathett; Shannon Willis; Randi E Foraker; Sakima Smith
Journal:  Heart Lung Circ       Date:  2016-07-18       Impact factor: 2.975

4.  Institutional volume of heart transplantation with left ventricular assist device explantation influences graft survival.

Authors:  Nicholas A Haglund; Irene D Feurer; Rashid M Ahmad; Thomas G DiSalvo; Daniel J Lenihan; Mary E Keebler; Kelly H Schlendorf; John M Stulak; Mark A Wigger; Simon Maltais
Journal:  J Heart Lung Transplant       Date:  2014-05-15       Impact factor: 10.247

5.  Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant.

Authors:  George J Arnaoutakis; Timothy J George; Jeremiah G Allen; Stuart D Russell; Ashish S Shah; John V Conte; Eric S Weiss
Journal:  J Thorac Cardiovasc Surg       Date:  2012-01       Impact factor: 5.209

6.  Center-level Utilization of Hepatitis C Virus-positive Donors for Orthotopic Heart Transplantation.

Authors:  Lauren V Huckaby; Laura M Seese; Robert Handzel; Yisi Wang; Gavin Hickey; Arman Kilic
Journal:  Transplantation       Date:  2021-12-01       Impact factor: 4.939

7.  Trends in the utilization of marginal donors for orthotopic heart transplantation.

Authors:  Lauren V Huckaby; Gavin Hickey; Ibrahim Sultan; Arman Kilic
Journal:  J Card Surg       Date:  2021-01-23       Impact factor: 1.778

8.  Characteristics Associated With High-Performing Pediatric Heart Transplant Centers in the United States From 2006 to 2015.

Authors:  Tajinder P Singh; Mandeep R Mehra; Kimberlee Gauvreau
Journal:  JAMA Netw Open       Date:  2020-11-02

Review 9.  Current stem cell delivery methods for myocardial repair.

Authors:  Calvin C Sheng; Li Zhou; Jijun Hao
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

10.  Introduction of a Framework for Dynamic Knowledge Representation of the Control Structure of Transplant Immunology: Employing the Power of Abstraction with a Solid Organ Transplant Agent-Based Model.

Authors:  Gary An
Journal:  Front Immunol       Date:  2015-11-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.